Folic Acid vs Methylfolate: The Distinction That Could Affect 40% of the Population

The distinction between folic acid and methylfolate is not an obscure biochemical technicality — it is clinically relevant to approximately 40–60% of the UK population who carry a genetic variant that impairs their ability to convert one to the other.

If you have been told to take folic acid and noticed no improvement in your energy, mood, or neurological symptoms — or if you're pregnant and taking the standard folic acid recommendation — this information could be genuinely important for you.

---

What Is Folate?

Folate is the umbrella term for a family of water-soluble B vitamins (vitamin B9) that are essential for: - DNA synthesis and repair — every dividing cell requires folate - Amino acid metabolism — conversion of homocysteine to methionine - Methylation reactions — production of SAMe (S-adenosylmethionine), the body's universal methyl donor - Neural tube development during early pregnancy - Red blood cell formation — deficiency causes megaloblastic anaemia - Neurotransmitter synthesis — serotonin, dopamine, and noradrenaline synthesis all depend on the methylation cycle

---

The Conversion Problem: MTHFR

Folic acid is a synthetic, oxidised form of folate used in supplements and fortified foods. It is not the form found in food (which is 5-methyltetrahydrofolate, or 5-MTHF) and cannot be directly used by the body.

To become biologically active, folic acid must be converted through a multi-step enzymatic process, with the final and rate-limiting step catalysed by MTHFR (Methylenetetrahydrofolate Reductase).

MTHFR converts folic acid (via 5,10-methyleneTHF) into 5-MTHF — the active, usable form.

Here is the critical issue: MTHFR genetic variants (polymorphisms) reduce this enzyme's activity:

- MTHFR C677T heterozygous (one copy): 40% reduction in MTHFR activity — affects approximately 40% of the European population - MTHFR C677T homozygous (two copies): 70% reduction — affects approximately 10–15% of the European population - MTHFR A1298C: Another common variant with clinical significance in combination

Combined, these variants affect an estimated 40–60% of UK adults to some degree.

The consequence: In individuals with significant MTHFR impairment, folic acid supplementation does not reliably raise active 5-MTHF levels in the way it does in those with normal MTHFR function. They may be supplementing with folic acid and remaining functionally folate-deficient at the cellular level.

---

The Folic Acid Masking Problem

There is a second, serious concern specific to folic acid:

Folic acid can mask vitamin B12 deficiency.

Folate deficiency and B12 deficiency both cause megaloblastic anaemia (large, immature red blood cells). Supplementing folic acid can normalise blood cell appearance and haemoglobin — masking the anaemia — while B12 deficiency continues to cause progressive neurological damage undetected.

This is not theoretical. Cases of severe, irreversible neurological damage from B12 deficiency masked by folic acid supplementation are documented in the medical literature.

The practical implication: Never supplement high-dose folic acid without also ensuring B12 adequacy. And in older adults especially — where both B12 deficiency and folate supplements are common — this interaction warrants attention.

---

The Cancer Debate: Ulrich and Beyond

The relationship between folic acid supplementation and cancer risk is genuinely controversial.

The protective story: - Adequate folate intake is associated with reduced colorectal cancer risk in observational studies - Low folate is associated with greater DNA damage and increased cancer risk

The problematic story: - A meta-analysis by Ulrich and Potter (2006) raised concerns that high-dose folic acid supplementation might promote the growth of pre-existing precancerous cells and small tumours — rather than preventing cancer from starting - The proposed mechanism: folate-dependent cellular proliferation may benefit existing abnormal cells as much as normal cells - Some RCTs of folic acid supplementation have shown increased rates of certain cancers, particularly prostate cancer (in the CAPS trial), though results are inconsistent

The current evidence: - Low-dose dietary folate or supplemental 5-MTHF is not associated with increased cancer risk - High-dose folic acid (>1,000mcg/day) in individuals with existing colorectal polyps or cancer history is where the concern is most plausible - Routine supplementation at 400–800mcg is considered safe by SACN and EFSA

The practical takeaway: Use 5-MTHF rather than folic acid where possible — the cancer concern relates specifically to unmetabolised folic acid accumulation, which does not occur with 5-MTHF.

---

Dietary Folate: The Real Sources

Food folate (5-MTHF and formyl-THF forms) is directly bioavailable without MTHFR conversion. However, dietary folate is: - Heat-sensitive (significant losses in cooking, particularly boiling) - Light-sensitive - The UK diet has declined in folate content as vegetable consumption has fallen

Best food sources: - Liver (chicken): 590mcg/100g — exceptionally rich - Chickpeas/lentils: 180–360mcg/100g (cooked) - Dark leafy greens (spinach, kale): 150–190mcg/100g - Asparagus: 150mcg/100g - Avocado: 90mcg per fruit - Eggs: 60mcg per egg - Fortified cereals: 100–200mcg/serving (as folic acid)

UK RNI: 200mcg/day for adults; 400mcg/day during pregnancy (or preconception).

---

Methylation Cycle and Methyl Donors

Understanding why folate form matters requires understanding the methylation cycle:

The cycle: 1. Folate (as 5-MTHF) donates a methyl group to convert homocysteine → methionine (B12 is the cofactor for this reaction) 2. Methionine is converted to SAMe — the universal methyl donor 3. SAMe donates methyl groups for hundreds of reactions (neurotransmitter synthesis, gene expression, myelin production, detoxification) 4. The demethylated product is returned to the cycle

Impaired methylation — from MTHFR variants, B12 deficiency, or folate deficiency — is associated with: - Elevated homocysteine (cardiovascular risk marker) - Reduced SAMe levels - Impaired neurotransmitter synthesis → low mood, anxiety - Impaired myelin production → neurological vulnerability - Impaired detoxification

Other key methyl donors that support the cycle: - Vitamin B12 (methylcobalamin) - Betaine (trimethylglycine — from beetroot and quinoa) - Choline (eggs, liver) - Riboflavin (B2) — required for MTHFR enzyme activity

For those with MTHFR variants, a comprehensive methylation support protocol includes all of these, not just methylfolate alone.

---

Forms Available and Their Applications

Folic Acid (Synthetic, Oxidised)

- Standard in most supplements and fortified foods - Requires MTHFR conversion — problematic in those with variants - Cheap to produce - Does not accumulate as unmetabolised folic acid at doses ≤400mcg in most people (the threshold where concern applies is higher doses in MTHFR carriers)

5-MTHF (L-Methylfolate / Methylfolate)

- The active, immediately usable form - Bypasses MTHFR entirely — effective regardless of genetic variant - Preferred for: MTHFR carriers, those with neurological or mood symptoms, those combining with B12, pregnancy - More expensive than folic acid - Sold as: Metafolin (brand), Quatrefolic, various "active folate" products

Folinic Acid (5-Formyltetrahydrofolate)

- An intermediate form, not identical to methylfolate - Converted to 5-MTHF via a different enzymatic step (not MTHFR) - Better tolerated than methylfolate in some individuals with MTHFR variants — particularly those who experience anxiety, agitation, or worsening mood on methylfolate (sometimes called "methylfolate side effects" related to overmethylation in sensitive individuals) - Used in certain clinical protocols as an alternative when methylfolate causes adverse reactions

---

Pregnancy: The High-Stakes Application

SACN and NICE recommend 400mcg folic acid daily from at least 4 weeks before conception through the first 12 weeks of pregnancy (for neural tube defect prevention).

However: - Women with MTHFR variants cannot effectively convert folic acid to active 5-MTHF - Several researchers (including Obeid and colleagues) have argued that 5-MTHF is the more appropriate recommendation for pregnancy supplementation, particularly in women with MTHFR variants - As MTHFR testing is not routinely performed, the risk that folic acid is being inadequately converted in a significant proportion of pregnant women is real

Current UK guidance has not been updated to reflect MTHFR considerations. Until it is, women who know they carry MTHFR variants (either through genetic testing or family history) should discuss 5-MTHF supplementation with their GP or midwife.

The dose in pregnancy: 400mcg is the standard dose for neural tube protection. Higher doses (5mg/day) are prescribed by GPs to women with previous neural tube defect pregnancies.

---

Supplementation Protocol by Profile

| Profile | Recommended Form | Dose | |---|---|---| | General adult, no symptoms | Folic acid or 5-MTHF | 400mcg/day | | Known MTHFR variant | 5-MTHF (methylfolate) | 400–1,000mcg/day | | Pregnancy (no known MTHFR) | Folic acid (standard) | 400mcg from 4 weeks pre-conception | | Pregnancy (known MTHFR) | 5-MTHF | 400–800mcg — discuss with GP | | Elevated homocysteine | 5-MTHF + methylcobalamin + B6 | Comprehensive methylation protocol | | Depression/anxiety + methylation concerns | 5-MTHF + methylcobalamin | 400–1,000mcg 5-MTHF | | Methylfolate sensitivity | Folinic acid | 400–800mcg |

---

The Bottom Line

Folic acid is not interchangeable with folate. For the 40-60% of the UK population with MTHFR variants, standard folic acid supplementation may be substantially less effective than the active methylfolate form. For pregnancy specifically, this is not an academic concern — neural tube closure depends on adequate active folate in the first weeks of development.

The solution is straightforward: where possible, choose supplements listing "L-methylfolate," "5-MTHF," "Metafolin," or "Quatrefolic" on the label. The cost difference is modest and the functional difference can be significant. If you experience anxiety, irritability, or other adverse effects from methylfolate, try folinic acid as an intermediate form instead.